NEW DELHI: On the occasion of World Sickle Cell Day, Indraprastha Apollo Hospitals announced a significant milestone in the treatment of Sickle Cell Disease (SCD), revealing that it has successfully performed more than 215 bone marrow transplants for patients suffering from the inherited blood disorder.
The achievement, led by renowned specialist and his multidisciplinary team, is being regarded as one of the largest single-centre experiences globally in providing curative treatment for Sickle Cell Disease.
The announcement comes at a crucial time, as India continues to shoulder a substantial portion of the world’s Sickle Cell Disease burden. Healthcare experts are now urging greater emphasis on prevention, newborn screening, genetic counselling and access to specialised treatment centres to reduce the long-term impact of the disease.
India Faces a Significant Sickle Cell Challenge
Sickle Cell Disease is a hereditary blood disorder that alters the shape and functioning of red blood cells. Instead of their normal round shape, the cells become crescent or “sickle” shaped, making it difficult for blood to flow smoothly through blood vessels.
The condition can trigger several life-threatening complications, including:
- Severe anaemia
- Recurrent episodes of intense pain
- Frequent infections
- Organ damage
- Stroke
- Reduced life expectancy
According to global estimates, nearly 300,000 to 400,000 children are born with Sickle Cell Disease every year, and India contributes approximately 10 to 13 per cent of these cases annually.
The disease particularly affects populations living in tribal and underserved communities across states. Experts say delayed diagnosis often results in irreversible damage and significantly impacts a patient’s quality of life.
Apollo Hospital’s Milestone in Curative Treatment
Over the past decade, Apollo’s Centre for Bone Marrow Transplant and Cellular Therapy has emerged as a leading destination for patients requiring advanced treatment.
Under the leadership of Dr. Gaurav Kharya, the hospital has treated patients not only from India but also from several countries in Africa, the Middle East and Asia, regions that continue to record a high prevalence of Sickle Cell Disease.
Bone marrow or stem cell transplantation currently remains the only established curative treatment available for many patients with severe forms of the disease.
The hospital says advances in transplant techniques and supportive care have significantly improved survival rates and post-treatment outcomes.
Bhavya’s Journey from Pain to Hope
One of the most inspiring stories shared by the hospital was that of five-year-old Bhavya.
Diagnosed during infancy, Bhavya experienced repeated painful episodes, frequent hospital admissions and dependence on blood transfusions at a very young age.
Due to the severity of his condition, doctors recommended a haplo-identical stem cell transplant, a procedure that uses a partially matched donor.
His sister became the donor, and under the supervision of Apollo’s specialist team, the transplant was successfully completed.
Doctors say Bhavya recovered without major complications and now has the opportunity to live a healthier, transfusion-free life.
A Second Success Story Offers New Hope
The hospital also highlighted the case of a 23-year-old woman who had been battling Sickle Cell Disease since the age of 10.
Over the years, she suffered recurrent episodes of severe pain and acute chest syndrome, a dangerous complication that can affect breathing and oxygen supply.
Despite living with the disease for over a decade, she successfully underwent a matched sibling donor stem cell transplant and recovered well. These success stories demonstrate how timely intervention and specialised treatment can transform lives.
Expert Speaks
Speaking on World Sickle Cell Day, Dr. Gaurav Kharya said, “India continues to carry a significant burden of Sickle Cell Disease and other inherited blood disorders, affecting thousands of families every year. While advances in transplant techniques and supportive care have made cure possible for a growing number of patients, prevention remains equally important.”
He further stressed that strengthening newborn screening, carrier detection, genetic counselling and early referrals to specialised centres can significantly reduce complications and improve outcomes.
National Mission Driving Awareness
India’s has renewed national attention on a disease that remained under-recognised for decades. The initiative aims to eliminate Sickle Cell Disease as a public health concern by 2047 through widespread screening, awareness campaigns and improved access to treatment.
Healthcare experts believe collaboration between governments, hospitals and communities will be crucial to achieving these ambitious goals.
Health Explained: Why This Matters
This announcement is important because it shifts the conversation around Sickle Cell Disease from lifelong management to potential cure.
Apollo Hospital’s achievement showcases how specialised healthcare institutions can change thousands of lives through advanced treatment and research. However, experts agree that treatment alone is not enough.
The larger message is prevention.
Families with a history of inherited blood disorders should consider genetic counselling before marriage or pregnancy. Newborn screening can help identify the disease early, allowing doctors to intervene before serious complications arise.
The news also underlines the importance of strengthening healthcare access in tribal and underserved regions where the disease burden remains highest.
Apollo Hospitals deserves appreciation not only for crossing the milestone of 215 transplants but also for demonstrating that with early diagnosis, modern medicine and specialised expertise, children and adults living with Sickle Cell Disease can look forward to healthier and longer lives.
